Saturday 17 October 2026
Export HLTHQ’s income statement to Excel — free account
Cue Health Inc.
HLTHQ Healthcare Health Information Services
Cue Health Inc.’s revenue for fiscal 2023 (year ended December 2023) was $70.9 million, down 85.3% from fiscal 2022.
0.00
0.00
NaN
Follow HLTHQ
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to December
| Group | Line | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | Trend | 2024e | 2025e | 2026e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price, $ | |||||||||||||||
| Price, $ | Low | — | — | — | — | — | — | — | 8.53 | 1.63 | 0.16 |
Analyst estimates 2024–2026 Powerpack |
|||
| High | — | — | — | — | — | — | — | 22.55 | 14.90 | 2.82 | |||||
| People | |||||||||||||||
| People | Employees | — | — | — | — | — | — | 1,254 | 1,585 | 1,515 | 726 | ||||
| Revenue/emp, $m | — | — | — | — | — | 0.00 | 0.02 | 0.39 | 0.32 | 0.10 | |||||
| Income, $m | |||||||||||||||
| Income, $m | Revenue | — | — | — | — | — | 7 | 23 | 618 | 483 | 71 | ||||
| Gross margin, % | — | — | — | — | — | 100.00 | 34.86 | 55.26 | 31.75 | (79.16) | |||||
| EBT | — | — | — | — | — | (21) | (47) | 119 | (204) | (369) | |||||
| EBT margin, % | — | — | — | — | — | (310.99) | (206.30) | 19.28 | (42.15) | (519.72) | |||||
| Net income | — | — | — | 0 | — | (21) | (47) | 86 | (194) | (373) | |||||
| Depreciation | — | — | — | — | — | 4 | 6 | 33 | 49 | 56 | |||||
| Per share, $ | |||||||||||||||
| Per share, $ | Revenue | — | — | — | — | — | 0.42 | 1.41 | 11.70 | 3.27 | 0.46 | ||||
| Earnings | — | — | — | — | — | (1.31) | (2.90) | 0.63 | (1.31) | (2.44) | |||||
| Cash flow | — | — | — | — | — | (0.82) | 5.68 | (0.18) | (0.76) | (0.90) | |||||
| Capex | — | — | — | — | — | (0.19) | (4.79) | (2.19) | (0.43) | (0.13) | |||||
| Free cash flow | — | — | — | — | — | (1.01) | 0.89 | (2.37) | (1.18) | (1.03) | |||||
| Book value | — | — | — | — | — | 0.00 | 4.59 | 13.38 | 3.89 | 1.64 | |||||
| Shares, m | — | — | — | — | — | 16 | 16 | 53 | 148 | 153 | |||||
| Valuation, × | |||||||||||||||
| Valuation, × | P/E | — | — | — | — | — | 17.01 | 17.01 | 6.29 | 0.00 | 0.00 | ||||
| P/S | — | — | — | — | — | 1.78 | 1.78 | 1.15 | 0.65 | 0.50 | |||||
| P/B | — | — | — | — | — | 0.00 | 0.00 | 1.00 | 0.55 | 0.14 | |||||
| EV/Sales | — | — | — | — | — | 2.04 | 2.04 | 0.47 | 0.15 | (0.65) | |||||
| EV/FCF | — | — | — | — | — | (5.24) | (5.24) | (2.30) | (0.42) | 0.29 | |||||
| Cash, $m | |||||||||||||||
| Cash, $m | Operating cash flow | — | — | — | — | — | (13) | 93 | (9) | (112) | (138) | ||||
| Capex | — | — | — | — | — | (3) | (78) | (116) | (63) | (20) | |||||
| Free cash flow | — | — | — | — | — | (16) | 15 | (125) | (175) | (158) | |||||
| Balance, $m | |||||||||||||||
| Balance, $m | Working capital | — | — | — | — | — | 11 | 28 | 503 | 300 | 67 | ||||
| Total debt | — | — | — | — | — | 7 | 7 | 3 | 1 | — | |||||
| Net debt | — | — | — | — | — | (7) | (120) | (420) | (241) | (82) | |||||
| Shareholders’ equity | — | — | — | — | — | — | 75 | 707 | 576 | 250 | |||||
| Returns, % | |||||||||||||||
| Returns, % | ROA | — | — | — | — | — | 0.00 | (29.94) | 5.27 | (23.74) | (72.21) | ||||
| ROIC | — | — | — | — | — | 0.00 | 0.00 | 41.52 | (38.37) | (146.40) | |||||
| ROE | — | — | — | — | — | 25.83 | 59.36 | 10.94 | (30.24) | (90.35) | |||||
Negative figures in brackets.
Fiscal years to Dec 2023 · latest quarter Dec 2023
Charts ten years each
Cue Health Inc. vs peers in Health Information Services (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| RNLXY Renalytix plc - Sponsored ADR | $17.2M | — (loss-making) | — | +13.73% (above 0%: growing) | n/m | +17.96% (above 0%: growing) | 19.16% | (783.91%) | Compare |
| BFRG Bullfrog AI Holdings Inc. | $9.9M | — (loss-making) | — | +2,054.00% (above 0%: growing) | n/m | −5.67% (below 0%: shrinking) | 49.63% | (658.82%) | Compare |
| ETAOF ETAO International Co., Ltd. | $9.8M | — (loss-making) | — | — | n/m | +37,595.70% (above 0%: growing) | — | 0.00% | Compare |
| HCTI Healthcare Triangle, Inc. | $7.4M | 0.0× | — (loss-making) | +158.38% (above 0%: growing) | n/m | +67.48% (above 0%: growing) | 22.48% | (44.28%) | Compare |
| MGRX Mangoceuticals, Inc. | $7.1M | — (loss-making) | — | −59.07% (below 0%: shrinking) | n/m | +79.27% (above 0%: growing) | 64.24% | (1,501.45%) | Compare |
| HLTHQ Cue Health Inc. | $6.9M | — (loss-making) | — (loss-making) | −87.19% (below 0%: shrinking) | n/m | +50.55% (above 0%: growing) | (90.14%) | (792.13%) | |
| ZCMD Zhongchao Inc. | $6.2M | — (loss-making) | — | +20.44% (above 0%: growing) | −550.00% (below 0%: shrinking) | +191.85% (above 0%: growing) | 41.67% | 0.00% | Compare |
| ACON Aclarion, Inc. | $5.6M | — (loss-making) | — (loss-making) | +30.57% (above 0%: growing) | n/m | −41.41% (below 0%: shrinking) | 32.94% | (11,506.75%) | Compare |
| VSEED VSee Health, Inc. | $2.8M | — (loss-making) | — (loss-making) | +48.02% (above 0%: growing) | n/m | −257.62% (below 0%: shrinking) | 13.20% | (172.69%) | Compare |
| Median of peers | $7.3M | — | — | +30.57% | — | +42.72% | 32.94% | (415.75%) |
Cue Health Inc. (HLTHQ) key facts
- Concern: Cue Health Inc.’s revenue for fiscal 2023 (year ended December 2023) was $70.9 million, down 85.3% from fiscal 2022.
- Cue Health Inc. (HLTHQ) is a Health Information Services company in the Healthcare sector.
- Return on equity was −90.4% and debt-to-equity 0.00.
- Its Piotroski F-score is 2 out of 9 and its Altman Z-score is −5.66 (distress zone) for fiscal 2023.